NCT07069998Not yet recruiting
AI-guided AF Treatment
Artificial Intelligent Guided Treatment of Atrial Fibrillation: A Randomized Controlled Pilot Study
Source: ClinicalTrials.gov · Last updated 17 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Two-centre, prospective, randomized, open-label, controlled pilot study to examine whether integrating an artificial intelligence virtual assistant (VA), instructed with the latest international guidelines on optimal patient management into the outpatient management of patients diagnosed with atrial fibrillation (AF) in the last 6 months, is feasible, acceptable and effective in reducing the need for regular medical assessment and the healthcare burden, reduce variability, and meets with participant satisfaction, without compromising participant safety and overall care quality.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 21 May 2025
- Start date
- 15 Jul 2025
- Primary completion date
- 26 May 2028
- Lead sponsor
- East and North Hertfordshire NHS Trust
- Diseases
- Atrial fibrillation
- NCT number
- NCT07069998
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 15 Jul 2025 to the primary completion date, 26 May 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Alternative potentially reversible causes of AF (such as surgery, sepsis, or thyroid dysfunction)
Other illness
- Severe comorbidities (such as physical impairment, cognitive impairment, and hearing loss) that could affect protocol adherence, in the opinion of the investigator
- Chronic Kidney Disease (CKD) stage 4-5 or on dialysis
- Medical illness with a life expectancy of less than 1 year
- Dementia or other cognitive impairment
Other
- Currently involved in another AF interventional clinical trial
- Being pregnant
Who the study is looking for
- Age ≥ 18 years
- Documented diagnosis of AF within the last 6 months
- Patient is at least mildly symptomatic. Presence of at least one of the symptoms like palpitation, dizziness, breathlessness, pre-syncope, and syncope with at least mild intensity
- Ability to understand and comprehend the study rationale, design, and process.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.